Skip to search.
 FTSE 100 Up 1.82%

More On HPTX

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
46.08 0.00(0.00%) 23 Apr 21:00
Add to Portfolio
Prev Close:46.08
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:43.00
Beta:-0.13
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:45.99 - 45.99
Volume:0
Avg Vol (3m):0
Market Cap:966.62m
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for HPTX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :N/A
Quarterly EPS Est (Mar-15) :N/A
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat orphan diseases in the United states, Canada, and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback